Companies › BCTX
BRIACELL THERAPEUTICS CORP (BCTX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001610820 · EDGAR filings · Updated 2026-06-26
BRIACELL THERAPEUTICS CORP (BCTX) has reported institutional ownership of 4.4%, with 15 institutional managers holding positions valued at $3.70M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-26 — Current report (8-K) filed
- 2026-06-09 — Quarterly report (10-Q) filed
- 2026-06-03 — Current report (8-K) filed
- 2026-06-02 — Prospectus supplement (424B5) filed
- 2026-03-31 — Current report (8-K) filed
- 2026-03-10 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BRIACELL THERAPEUTICS CORP has 15 institutional holders and institutional ownership of 4.4%.
Data flags from SEC filings
Related companies
FEMASYS INC (FEMY) · Incannex Healthcare Inc (IXHL) · PRECIPIO INC (PRPO) · TIZIANA LIFE SCIENCES LTD (TLSA) · Rockwell Medical Inc (RMTI) · ENLIVEX LTD COM (ENLV)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.